Manufacturing to the Highest Standards
Quality at the Core
At Amarox Pharma France, quality is not a department—it is a culture. Every step of our production process is governed by strict quality management systems aligned with international regulatory requirements.
Our parent company Hetero operates 38 state-of-the-art manufacturing facilities approved by the most stringent global regulatory authorities, ensuring every product that reaches patients meets the highest benchmarks of safety and efficacy.
Quality Standards We Live By
Our Framework
Good Manufacturing Practice (GMP)
All our products are manufactured in compliance with EU GMP standards, ensuring consistent quality at every stage of production from raw materials to finished product.
REGULATORY COMPLIANCE
Full compliance with French and European regulatory frameworks. Our products are approved by the ANSM (Agence Nationale de Sécurité du Médicament) and meet EMA standards.
BIOEQUIVALENCE TESTING
Rigorous bioequivalence studies confirm that our generic medicines deliver the same therapeutic effect as the original brand-name medicines they replace.
QUALITY CONTROL
Every batch undergoes extensive quality control testing including identity, purity, potency, and dissolution testing before release to the market.
SUPPLY CHAIN INTEGRITY
Our supply chain is monitored end-to-end to ensure the integrity of our medicines from manufacturing through to delivery to patients across France.
PHARMACOVIGILANCE
Ongoing monitoring of our products post-approval ensures we proactively identify and respond to any safety signals, protecting patients at all times.
Regulatory Approvals
& Certifications
Our manufacturing facilities are approved by the world's most stringent regulatory authorities.
ANSM
France
EMA
European Medicines Agency
USFDA
United States
MHRA
United Kingdom
WHO GMP
World Health Organisation
EU GMP
European Union